These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23842688)

  • 81. Vascular disease: Ramipril improves walking times in patients with PAD.
    Lim GB
    Nat Rev Cardiol; 2013 Apr; 10(4):180. PubMed ID: 23438689
    [No Abstract]   [Full Text] [Related]  

  • 82. ACP Journal Club. Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication.
    Jaar BG
    Ann Intern Med; 2013 Jun; 158(12):JC7. PubMed ID: 23778931
    [No Abstract]   [Full Text] [Related]  

  • 83. Ramipril for treatment of intermittent claudication.
    Poredos P
    Vasa; 2013 Jul; 42(4):237-8. PubMed ID: 23823855
    [No Abstract]   [Full Text] [Related]  

  • 84. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 85. PURLs: ramipril for claudication?
    Stephens LA; Rogers N; Stevermer JJ
    J Fam Pract; 2013 Oct; 62(10):579-80. PubMed ID: 24143348
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ramipril improves walking times and quality of life in patients with stable intermittent claudication.
    Brittenden J
    Evid Based Med; 2014 Feb; 19(1):16. PubMed ID: 23842688
    [No Abstract]   [Full Text] [Related]  

  • 87. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
    Hunter MR; Cahoon WD; Lowe DK
    Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials.
    Shahin Y; Mazari F; Chetter I
    Int J Surg; 2011; 9(3):209-13. PubMed ID: 21195215
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Peripheral arterial disease: Treatment].
    Desormais I; Aboyans V; Pesteil F; Lacroix P
    Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Medical management of claudication.
    Ratchford EV
    J Vasc Surg; 2017 Jul; 66(1):275-280. PubMed ID: 28533077
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Management of patients with intermittent claudication].
    Fiessinger JN; Sapoval M; Julia P
    Rev Prat; 2005 Jun; 55(11):1190-2, 1195-7. PubMed ID: 16164064
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ramipril: a review of its use in preventing cardiovascular outcomes in high-risk patients.
    Anderson VR; Perry CM; Robinson DM
    Am J Cardiovasc Drugs; 2006; 6(6):417-32. PubMed ID: 17192135
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Peripheral arterial disease.
    Hiatt WR; Nehler MR
    Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.